Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Chronic Cough Market from 2024 to 2025?

The market size of chronic cough has expanded significantly over the past few years. The projections show that it will increase from $8.22 billion in 2024 to $8.9 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. The historic growth in the market can be traced back to factors such as the commonality of respiratory conditions, environmental considerations and air contamination, smoking and tobacco usage, respiratory infections, allergies and sensitivity towards the environment.

What Is the Projected Market Size of the Chronic Cough Market?

Significant expansion is anticipated for the chronic cough market in the upcoming years, with a projection to reach $12.89 billion by 2029, and a compound annual growth rate (CAGR) of 9.7%. The predicted growth during this period can be ascribed to the influence of emerging therapies designed to target specific pathways, the broadening knowledge related to reflux-induced cough, the global drive to cease smoking, and the enforcement of environmental and occupational health policies. Future trends within this period include breakthroughs in diagnostic technology, a focus on patient-oriented strategies, innovation in therapeutic solutions for neurogenic cough, the use of telehealth for the management of chronic cough, and ongoing research into central sensitization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

Who are the Major Competitors in the Chronic Cough Market Outlook?

Major companies operating in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

What Is Fueling Growth in the Chronic Cough Market?

As the occurrence of cough increases, it is predicted to fuel the expansion of the chronic cough market. Coughing is a reflex response that is often prompted by irritation, mucus, or foreign bodies. It serves to clean the air passages by vigorously expelling air from the lungs. Chronic coughing is defined as a cough that endures for at least eight weeks. Hence, when cough incidences increment, the cases of chronic cough also escalate. For instance, in March 2022, as reported by the Florida Health, a Department of Healthcare in the US, there were 80 patients found in 2021 with incidences of 41.0 and 1.4 per 100,000 years, respectively. 28 cases of pertussis were registered across 13 countries in 2023. Additionally, in March 2022, the Statens Serum Institut, a Denmark-based disease surveillance department, reported that the count of pertussis cases saw an increase of 41% from November 2022 to April 2023, compared to the period from November 2021 to April 2022 in Denmark. Thus, the increasing prevalence of cough is stimulating the chronic cough market’s expansion.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12109&type=smp

Which Chronic Cough Market Segments Are Growing the Fastest?

The chronic cough market covered in this report is segmented –

1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes

2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route Of Administrations

3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

2) By Corticosteroids: Inhaled Corticosteroids, Systemic Corticosteroids

3) By Decongestants: Oral Decongestants, Nasal Decongestants

4) By Combination Drug: Antihistamine And Decongestant Combinations, Cough Suppressant And Expectorant Combinations

5) By Antibiotics: Macrolides, Penicillins, Cephalosporins

6) By Acid Blockers: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists

7) By Other Drug Classes: Mucolytics, Cough Suppressants, Herbal Remedies

Which Industry Trends Are Shaping the Future of the Chronic Cough Market?

Leading players in the chronic cough market are focusing on the development of innovative products such as biosimilars to consolidate their market standing. Biosimilars are employed in the management of a range of conditions, including cancer, autoimmune diseases, and diabetes, and are a cost-effective alternative to current biologics. For example, in July 2024, Sandoz, a Swiss-based pharmaceutical company, rolled out its biosimilar, Pyzchiva (ustekinumab) throughout Europe. This move targets various chronic inflammatory diseases such as plaque psoriasis, psoriatic arthritis, and Crohn’s disease. The biosimilar’s launch is noteworthy, as it’s the first of its kind in Europe with all the strengths of the reference medicine, including the starting dosage for Crohn’s disease patients. Collaboratively developed with Samsung Bioepis, Sandoz’s goal is to increase accessibility to efficient treatments for the countless individuals impacted by these disorders. The move signifies Sandoz’s dedication to offering economical healthcare solutions and enhancing patients’ quality of life across Europe.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

Which Countries Are Leading the Chronic Cough Market?

North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12109

This Report Delivers Insight On:

1. How big is the chronic cough market, and how is it changing globally?

2. Who are the major companies in the chronic cough market, and how are they performing?

3. What are the key opportunities and risks in the chronic cough market right now?

4. Which products or customer segments are growing the most in the chronic cough market?

5. What factors are helping or slowing down the growth of the chronic cough market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model